MEDGm Tirzepatide Review: $399/Month, and the $279 That Lasts One Month (2026)

MEDGm sells its compounded tirzepatide injection at $399 a month, month to month, and that is the standing rate. The $279 the order summary shows first covers the first month only, after a coupon the page applies without a code. Neither figure is readable up front, because the ladder opens on a tokenized page at the end of a sixteen-screen intake, walked on 1 September 2026.¹

What MEDGm charges once the intake is behind you

Past that gate the pricing is unusually complete, because every prepay tier carries the amount actually charged, not only a monthly equivalent. The totals are $1,047 for three months, $1,914 for six and $3,228 for twelve, each billed up front on the day you enroll and each renewing automatically. The order summary itemizes the clinician visit, shipping, refills and provider messaging at no extra charge, and no lab or dose-change fee is priced anywhere.

Three starting prices, none of them the rate you pay

Before the intake, the GLP-1 page advertises STARTING AT $179, a semaglutide rate rather than a tirzepatide one, and a first-month rate at that. The standing semaglutide price is $299, and removing the automatically applied coupon on the live page rewrites the panel to say so. On the treatments page itself, cards reading $199 and $299 match no figure in the ladder printed directly beneath them. That page's FAQ promises the price never increases as the dose goes up, which holds for the dose and not for the bill, because the month-to-month rate rises at the first renewal.

What the company discloses about itself

The pharmacy disclosure is the strongest thing here: the Terms name RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx, each with a street address and a phone number. The 503A and 503B designations are given as a class covering all four rather than per pharmacy, and which one fills an order is not stated. The operating entity is MEDGm, LLC, a Delaware limited liability company that publishes no principal place of business. A certification badge sits in the footer as an image served from MEDGm's own domain, and no seal identifier appears anywhere, so nothing there says which certification it refers to.

The brand-vs-compounded question

This is compounded tirzepatide, made by a pharmacy rather than by Lilly, and it is not itself an FDA-approved finished product. Our guide to whether compounded tirzepatide is still legal in 2026 sets out where that stands now.

How the care model holds up

In its favor: a named pharmacy list, a published phone number and a fifty-state claim in the Terms that the intake's own state selector matches exactly. Against it: the twelve-month bundle renews for another full $3,228 up to ten days early, unless you cancel at least 72 hours ahead. Once a multi-month term is charged, no part of it comes back if you cancel voluntarily.

Does the drug work? (Separate from the provider)

Judge a seller on what it charges and what it discloses; judge the molecule on its own record. Tirzepatide's record is strong: roughly 15% to 21% of body weight over 72 weeks in SURMOUNT-1², and a clear win over semaglutide in a direct comparison³. Both trials ran the branded product at approved doses rather than a compounded copy, and our tirzepatide evidence guide carries the detail.

The honest verdict

MEDGm is candid once you are inside and evasive on the way in, and that gap is the review. The ladder is complete and checkable, but you reach it only by handing over a name, an email and a phone number. If you would rather read a price with no intake in front of it, Mondae puts $126 per 28 days on a public product page, and Nex Gen Health Rx publishes every prepay rung from $239 per 30 days before asking for anything. The ranked field sits in our best tirzepatide providers list.